5 February 2026
Actorius and ACTREC Partner to Advance Clinical Cancer Research.
A collaborative research initiative to study the practical utility of Circulating Tumor Cells and their capture and depletion from patient's blood as possible aid to adjunct therapeutics.
Big step forward for Actorius Innovations and Research 🙌
Actorius recently signed an MOU with Advanced Centre for Treatment, Research and Education in Cancer(ACTREC) to collaborate on clinical studies and research spanning - practical utility of Circulating Tumor Cells and their capture and depletion from patient’s blood as possible aid to adjunct therapeutics.
Slowing down or blocking metastasis cascade in early stage patients.
Extremely bold and breakthrough innovation hypothesis.
This partnership is about taking science closer to patients—generating meaningful real-world evidence, strengthening translational research, and asking the right clinical questions where it truly matters.
The MOU was signed by Dr. Pankaj Chaturvedi, Director, ACTREC, and Dr. Jayant Khandare, Co-Founder & CSO, Actorius Innovations and Research.
Excited about what lies ahead and the impact this collaboration can create together.
Aravindan Vasudevan Rick Kamble
Never Miss a Breakthrough.
Get the latest news and innovations from OncoDiscover delivered straight to your inbox.
Early detection is half the battle won.
Book a Test
Simply book a CTC Test online or over a phone call and schedule a visit by our registered phlebotomists.
Sample Collection
Upon booking the CTC Test, one of our registered phlebotomists shall visit and collect 10 ml of patient’s blood sample.
Receive Report
A set of diagnostics will be run on the patient’s blood sample and the report shall be provided in 7 working days upon receipt of sample on site.